Literature DB >> 22302831

Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.

Ryousuke Satou1, Kayoko Miyata, Romer A Gonzalez-Villalobos, Julie R Ingelfinger, L Gabriel Navar, Hiroyuki Kobori.   

Abstract

Renal inflammation modulates angiotensinogen (AGT) production in renal proximal tubular cells (RPTCs) via inflammatory cytokines, including interleukin-6, tumor necrosis factor α, and interferon-γ (IFN-γ). Among these, the effects of IFN-γ on AGT regulation in RPTCs are incompletely delineated. This study aimed to elucidate mechanisms by which IFN-γ regulates AGT expression in RPTCs. RPTCs were incubated with or without IFN-γ up to 48 h. AGT expression, STAT1 and STAT3 activities, and SOCS1 expression were evaluated. RNA interference studies against STAT1, SOCS1, and STAT3 were performed to elucidate a signaling cascade. IFN-γ decreased AGT expression at 6 h (0.61±0.05, ratio to control) and 12 h (0.47±0.03). In contrast, longer exposure for 24 and 48 h increased AGT expression (1.76±0.18, EC(50)=3.4 ng/ml, and 1.45±0.08, respectively). IFN-γ treatment for 6 h strongly induced STAT1 phosphorylation and SOCS1 augmentation, and decreased STAT3 activity. However, STAT1 phosphorylation and SOCS1 augmentation waned at 24 h, while STAT3 activity increased. RNA interference studies revealed that activation of STAT1-SOCS1 axis decreased STAT3 activity. Thus, IFN-γ biphasically regulates AGT expression in RPTCs via STAT3 activity modulated by STAT1-SOCS1 axis, suggesting the STAT1-SOCS1 axis is important in IFN-γ-induced activation of the intrarenal renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302831      PMCID: PMC3336777          DOI: 10.1096/fj.11-195198

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  44 in total

Review 1.  Tissue renin angiotensin systems.

Authors:  Richard N Re
Journal:  Med Clin North Am       Date:  2004-01       Impact factor: 5.456

2.  In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system.

Authors:  J R Ingelfinger; W M Zuo; E A Fon; K E Ellison; V J Dzau
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Structure and expression of the mouse angiotensinogen gene.

Authors:  K Tamura; K Tanimoto; S Takahashi; M Sagara; A Fukamizu; K Murakami
Journal:  Jpn Heart J       Date:  1992-01

4.  Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle.

Authors:  E Mascareno; M Dhar; M A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

5.  Tissue angiotensin system in cardiovascular medicine. A paradigm shift?

Authors:  V J Dzau; R Re
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

Review 6.  The suppressors of cytokine signalling (SOCS).

Authors:  B T Kile; W S Alexander
Journal:  Cell Mol Life Sci       Date:  2001-10       Impact factor: 9.261

Review 7.  Suppressors of cytokine signalling: SOCS.

Authors:  Lykke Larsen; Carsten Röpke
Journal:  APMIS       Date:  2002-12       Impact factor: 3.205

8.  Evidence for the involvement of distinct signal transduction pathways in the regulation of constitutive and interferon gamma-dependent gene expression of NADPH oxidase components (gp91-phox, p47-phox, and p22-phox) and high-affinity receptor for IgG (Fc gamma R-I) in human polymorphonuclear leukocytes.

Authors:  M A Amezaga; F Bazzoni; C Sorio; F Rossi; M A Cassatella
Journal:  Blood       Date:  1992-02-01       Impact factor: 22.113

9.  PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney.

Authors:  Y Terada; K Tomita; H Nonoguchi; F Marumo
Journal:  Kidney Int       Date:  1993-06       Impact factor: 10.612

Review 10.  Regulation of cytokine signaling by SOCS family molecules.

Authors:  Minoru Fujimoto; Tetsuji Naka
Journal:  Trends Immunol       Date:  2003-12       Impact factor: 16.687

View more
  36 in total

Review 1.  Inflammatory cytokines regulate renal sodium transporters: how, where, and why?

Authors:  Allison E Norlander; Meena S Madhur
Journal:  Am J Physiol Renal Physiol       Date:  2017-04-12

2.  Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension.

Authors:  Liang Xiao; Annet Kirabo; Jing Wu; Mohamed A Saleh; Linjue Zhu; Feng Wang; Takamune Takahashi; Roxana Loperena; Jason D Foss; Raymond L Mernaugh; Wei Chen; Jackson Roberts; John W Osborn; Hana A Itani; David G Harrison
Journal:  Circ Res       Date:  2015-07-08       Impact factor: 17.367

Review 3.  Immune cell trafficking, lymphatics and hypertension.

Authors:  Dakshnapriya Balasubbramanian; Catalina A Lopez Gelston; Joseph M Rutkowski; Brett M Mitchell
Journal:  Br J Pharmacol       Date:  2018-06-25       Impact factor: 8.739

4.  Association of estimated sodium and potassium intake with blood pressure in patients with systemic lupus erythematosus.

Authors:  A Barnado; A Oeser; Y Zhang; C R Okafor; J Titze; C M Stein; C P Chung
Journal:  Lupus       Date:  2016-07-11       Impact factor: 2.911

Review 5.  Roles of collecting duct renin and (pro)renin receptor in hypertension: mini review.

Authors:  Alexis A Gonzalez; Minolfa C Prieto
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-03-16

6.  Advanced Glycation End Products Stimulate Angiotensinogen Production in Renal Proximal Tubular Cells.

Authors:  Joseph M Garagliano; Akemi Katsurada; Kayoko Miyata; Andrei V Derbenev; Andrea Zsombok; L Gabriel Navar; Ryousuke Satou
Journal:  Am J Med Sci       Date:  2018-10-24       Impact factor: 2.378

Review 7.  Linking inflammation and hypertension via LNK/SH2B3.

Authors:  Bethany L Dale; Meena S Madhur
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-03       Impact factor: 2.894

Review 8.  Inflammation, immunity, and hypertensive end-organ damage.

Authors:  William G McMaster; Annet Kirabo; Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 9.  Renal generation of angiotensin II and the pathogenesis of hypertension.

Authors:  Jorge F Giani; Tea Janjulia; Brian Taylor; Ellen A Bernstein; Kandarp Shah; Xiao Z Shen; Alicia A McDonough; Kenneth E Bernstein; Romer A Gonzalez-Villalobos
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 10.  Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.

Authors:  Hiroyuki Kobori; Maki Urushihara
Journal:  Pflugers Arch       Date:  2012-08-24       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.